Sign in
4

Changes in Ownership

Eledon Pharmaceuticals, Inc. Filed Acc 0001209191-23-026731

Options or other derivatives

  • Director acquired 150,437 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Ogier Walter C Director 2023-05-01 Grant or award · Stock Option (right to buy) +150,437 150,437 D: show line 1 in the form
Loading xslF345X04/doc4.xml…